Stockscreener 앱 받기
0.00
100.00%
-1.16
시간 외 거래:
1.15
1.15
+
Hookipa Pharma Inc 주식(HOOK)의 최신 뉴스
HOOK stock trades quietly as HOOKIPA Pharma focuses on vaccine pipeline - ad-hoc-news.de
HOOKIPA Pharma Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
HOOKIPA Pharma Inc Market Sentiment - Benzinga España
HOOKIPA Pharma (HOOK) AGM 2024 Summary - Quartr
Hookipa Pharma Inc (HOOK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Hookipa Pharma focuses on clinical-stage immunotherapies as investor interest in biotech stays eleva - Ad-hoc-news.de
HOOKIPA Pharma Inc (HOOK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HOOKIPA Pharma Inc (HOOK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HOOKIPA Pharma Inc (HOOK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HOOKIPA Pharma Inc (HOOK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HOOKIPA Pharma Inc (HOOK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Institutional Confidence - TradingKey
HOOKIPA Pharma Inc (HOOK) Valuation: PE, PB & Fair Value Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HOOKIPA Pharma Inc (HOOK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Immuno-oncology small cap after recent funding and pipeline - AD HOC NEWS
Stock Quote - StocksToTrade
HOOKIPA Pharma stock (US43906K1007): cash runway update and pipeline focus after latest quarterly re - AD HOC NEWS
HOOKIPA Pharma stock (US43906K1007): pipeline update keeps immunotherapy story in focus - AD HOC NEWS
HOOKIPA Pharma Inc.Common Stock (Nasdaq:HOOK) Stock Quote - The Chronicle-Journal
HOOKIPA Pharma Inc stock (US43906K1007): Delisted to OTC amid price volatility - AD HOC NEWS
TradingKey - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Biotech focuses on infectious disease and oncology pipeline - AD HOC NEWS
HOOKIPA Pharma Inc stock (US43906K1007): Is its viral vector platform strong enough to unlock biotec - AD HOC NEWS
Can HOOKIPA Pharma Inc reach all time highs this yearQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Earnings Report: Can HOOKIPA Pharma Inc reach all time highs this year - baoquankhu1.vn
New Highs: How does HOOKIPA Pharma Inc compare to its peersQuarterly Risk Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
Winners Losers: Is HOOKIPA Pharma Inc stock a smart retirement pick2026 Support & Resistance & Safe Capital Allocation Plans - baoquankhu1.vn
HOOKIPA Pharma Inc Stock: Areola Virus Vaccine Innovator Seeks Prophylactic Breakthrough with ISIN U - AD HOC NEWS
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
NeoTrail Therapeutics, Inc. completed the acquisition of Oncology Assets from HOOKIPA Pharma Inc. (OTCPK : HOOK). - MarketScreener
Breakout Move: How does HOOKIPA Pharma Inc compare to its peers2026 Sector Review & Real-Time Volume Triggers - baoquankhu1.vn
HOOKIPA Pharma Inc stock faces renewed scrutiny after failed merger and pipeline updates in biotech - AD HOC NEWS
Gilead (GILD) to Acquire HOOK for $10 million - msn.com
HOOKIPA Pharma Stock: What Latest Pipeline Moves Mean for U.S. Investors - AD HOC NEWS
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - Yahoo Finance
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewswire
HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale - MSN
HOOK Stock Price and Chart — OTC:HOOK - TradingView
HOOK Stock Price, Quote & Chart | HOOKIPA PHARMA INC (NASDAQ:HOOK) - ChartMill
[S-8 POS] HOOKIPA Pharma Inc. SEC Filing - Stock Titan
Hookipa, having sold off vaccines to Gilead, opts to wind down - Fierce Biotech
Hookipa Pharma to Delist from Nasdaq Amid Asset Sale - The Globe and Mail
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - Yahoo Finance
HOOKIPA Pharma(Delisted) (HOOK) Revenue BreakdownMain Composition - Moomoo
Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs - Fierce Biotech
HOOK Stock Price, News & Analysis - Stock Titan
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com
Poolbeg slumps as Hookipa merger is called off - pharmaphorum
HOOKIPA Pharma Inc. Announces Decision Against All-Share Acquisition of Poolbeg Pharma plc | HOOK Stock News - Quiver Quantitative
HOOKIPA Pharma announces enrollment completion of Phase 1b clinical trial evaluating HB-500 for the treatment of HIV - European AIDS Treatment Group
Poolbeg Pharma PLC (AIM:POLB) Offer Update – Extension to PUSU Deadline - Share Talk
HOOKIPA Pharma seeks court validation for stockholder actions By Investing.com - Investing.com UK
Poolbeg Pharma plc ('Poolbeg”) and HOOKIPA Pharma Inc. ('HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - The Manila Times
Poolbeg Pharma Update On Potential Combination With HOOKIPA - DirectorsTalk Interviews
HOOKIPA Pharma IncFORM 8 (OPD) - ChartMill
Poolbeg Pharma plc and HOOKIPA Pharma Inc. Provide Update on Potential Combination and Fundraise - Quiver Quantitative
London-listed Poolbeg discussing Hookipa merger - pharmaphorum
HOOKIPA Pharma in early talks to acquire Poolbeg - The Pharma Letter
Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program - Yahoo Finance
HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program - marketscreener.com
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates - The Manila Times
Hookipa Pharma Reports Q3 Earnings Amid Strategic Changes - TipRanks
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker - GlobeNewswire
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 - The Manila Times
0.05%
1.96%
자본화:
|
볼륨(24시간):